| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.008 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |